Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Fisogatinib |
| Trade Name | |
| Synonyms | BLU554|BLU-554 |
| Drug Descriptions |
Fisogatinib (BLU-554) binds to and inhibits FGFR4 (a receptor for FGF19), potentially resulting in decreased proliferation of FGFR4 and FGF19-expressing tumor cells (PMID: 29547556, PMID: 31575540, PMID: 31575541). |
| DrugClasses | FGFR4 Inhibitor 10 |
| CAS Registry Number | 1707289-21-1 |
| NCIT ID | C123826 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Fisogatinib | Fisogatinib | 0 | 1 |
| Fisogatinib + Sugemalimab | Fisogatinib Sugemalimab | 0 | 0 |